Chatzikonstantinou Thomas,...,Antic Darko A,...,Tomic-Vujovic Kristina,...,(broj koautora 75) (2025) Survival differences of patients with treatment-naive CLL between the chemoimmunotherapy and BTKi eras: An eric study., BLOOD, vol. 146, br. , str. 5664-5666 (Meeting Abstract) 

Chatzikonstantinou Thomas,...,Antic Darko A,...,Tomic-Vujovic Kristina,...,(broj koautora 64) (2025) Dissecting the heterogeneity of IGHV-mutated CLL: An eric study, BLOOD, vol. 146, br. , str. 2120-2121 (Meeting Abstract) 

Chatzikonstantinou Thomas,...,Mihaljevic Biljana S,Milosevic Ivana D,...,Tomic Kristina,...,Vukovic Vojin M,...,Antic Darko A,...,(broj koautora 123) (2024) Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL, HEMASPHERE, vol. 8, br. 9, str. - (Letter) 

Chatzikonstantinou Thomas,...,Mihaljevic Biljana S,Milosevic Ivana D,...,Tomic Kristina,...,Vukovic Vojin M,...,Antic Darko A,...,(broj koautora 142) (2023) Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY, ECLINICALMEDICINE, vol. 65, br. , str. - (Article) 

Chatzikonstantinou Thomas,...,Mihaljevic Biljana S,Milosevic Ivana D,...,Tomic Kristina,...,Vukovic Vojin M,...,Antic Darko A,...,(broj koautora 129) (2021) Real-World Evidence on Therapeutic Strategies and Treatment-Sequencing in Patients with Chronic Lymphocytic Leukemia: An International Study of Eric, the European Research Initiative on CLL, BLOOD, vol. 138, br. , str. - (Meeting Abstract) 

Chatzikonstantinou Thomas,...,Antic Darko A,...,Milosevic Ivana D,...,(broj koautora 113) (2021) COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study, LEUKEMIA, vol. 35, br. 12, str. 3444-3454 (Article)